Beacon pharma incurs loss in Jan-Mar
At the end of the first three quarters of the fiscal year 2023-24, its earnings per share was Tk2.38, lowering from Tk2.57 in the same period a year ago
Beacon Pharmaceuticals reported that it incurred a loss in the January-March quarter of the current fiscal year.
According to the financial statement filing on the Dhaka bourse, its loss per share was Tk0.95 during the quarter.
At the end of the first three quarters of the fiscal year 2023-24, its earnings per share was Tk2.38, lowering from Tk2.57 in the same period a year ago.
Keep updated, follow The Business Standard's Google news channel
Its share price fell by 2.95% to Tk177.90 in the opening session on Monday.
